Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer
American Journal of Translational Research · 2024 · 16 (4) · 1424-1441
DOI: 10.62347/oiqb4997 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2024. Verfasst von Ting Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's Health Care, Maternal and Child Health Hospital of Hubei Province Wuhan, Hubei, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Women's Health Care, Maternal and Child Health Hospital of Hubei Province Wuhan, Hubei, China.
Zitieren
APA
Xie, T., Liu, T., Wu, L., & Yi, N. (2024). Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer. American Journal of Translational Research, 16(4), 1424-1441. https://doi.org/10.62347/oiqb4997
Vancouver
Xie T, Liu T, Wu L, Yi N. Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer. American Journal of Translational Research. 2024;16(4):1424-1441. doi:10.62347/oiqb4997
BibTeX
@article{Xie2024,
author = {Xie, Ting and Liu, Tingting and Wu, Lan and Yi, Nianhua},
title = {Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer},
journal = {American Journal of Translational Research},
year = {2024},
volume = {16},
number = {4},
pages = {1424--1441},
doi = {10.62347/oiqb4997}
}
EUVIMED